in vivo-like Scaffold-free 3D in vitro Models of Muscular Dystrophies: The Case for Anchored Cell Sheet Engineering in Personalized Medicine

Alireza Shahin-Shamsabadi,John Cappuccitti

DOI: https://doi.org/10.1101/2024.11.16.623949

2024-11-18

Abstract:Progress in understanding the underlying mechanisms of muscle dystrophies and finding effective treatments for them has been hindered by the absence of relevant in vitro models for biomedical research. In this study, an entirely scaffold-free cell sheet engineering-based platform is used to make such in vitro models using patient-specific cells. Unlike reductionist bottom-up approaches, this holistic biofabrication method, termed anchored cell sheet engineering, effectively replicated mature cell phenotypes and tissue- and disease-specific ECM deposited by the cells themselves. Robust anchored 3D muscle fibers were developed using primary cells from both healthy individuals and patients with Duchenne dystrophy and Myotonic dystrophy type 1. Through a combination of histology, immunostaining, and proteomics analysis, it was demonstrated that these models formed mature constructs that closely resembled in vivo conditions, outperforming traditional 2D cultures in their translation potential. Models of diseased tissues, analyzed through various analysis, accurately reflected key phenotypic features of the respective diseases. Furthermore, when treated with therapeutically beneficial drugs, the detailed changes in their proteomic profiles were documented. This novel in vitro modeling approach, compared to other 3D techniques that use exogenous scaffolding or bioink, provides a promising platform for advancing the development of muscle dystrophy models, among other conditions.

Bioengineering

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is that the current in - vitro models used for studying muscular dystrophies are unable to fully simulate in - vivo conditions, resulting in limitations in understanding disease mechanisms and developing effective treatment methods. Specifically:

1. **Lack of effective in - vitro models**: Traditional two - dimensional (2D) cell culture systems are easy to operate and have good reproducibility, but they are overly simplified and cannot accurately replicate the complex cell microenvironment and interactions in living tissues, which leads to differences between in - vitro findings and clinical results.

2. **The need for personalized medicine**: Since many gene mutations in muscular dystrophy do not exist in existing animal models, combined with ethical issues and high costs of animal experiments, there is an urgent need to develop in - vitro models that can reflect the pathological characteristics of individual patients to support the development of personalized medicine.

3. **3D - Scaffold - free cell sheet engineering**: To solve the above problems, this study introduced a new method based on "anchored cell sheet engineering", using patient - specific cells to construct a completely scaffold - free three - dimensional (3D) in - vitro model. This method can effectively replicate mature cell phenotypes and tissue - specific and disease - specific extracellular matrices (ECM) deposited by the cells themselves, thereby more accurately simulating in - vivo conditions.

Through these improvements, the study aims to provide a platform closer to in - vivo conditions for in - depth study of the pathogenesis of muscular dystrophy and to accelerate the process of new drug discovery.